Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Not applicableUnknownNCT03257449
What this trial is testing

Effect of Viscous Soluble Fibres on Body Weight

Who this might be right for
Overweight and ObesityT2DM (Type 2 Diabetes Mellitus)General Population
Unity Health Toronto 1,268
Not applicableStudy completedNCT03127696
What this trial is testing

Randomised Placebo-controlled Study of FMT to Impact Body Weight and Glycemic Control in Obese Subjects With T2DM

Who this might be right for
Type2 DiabetesType 2 Diabetes MellitusObese
Chinese University of Hong Kong 61
Not applicableUnknownNCT01989988
What this trial is testing

DMBSS-A Randomized Trial of Different Laparoscopic Gastric Bypass Surgery in Patients With Obesity-related T2DM

Who this might be right for
Diabetes Mellitus Type 2 in Obese
Min-Sheng General Hospital 60
Large-scale testing (Phase 3)Study completedNCT02043054
What this trial is testing

Effects of Liraglutide in Young Adults With Type 2 DIAbetes (LYDIA)

Who this might be right for
Type 2 Diabetes MellitusCardiovascular Disease
University of Leicester 90
Early research (Phase 1)Study completedNCT06279234
What this trial is testing

Learn How Different Amounts of PF-06954522 Are Tolerated and Act in Adults With Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus (T2DM)Obesity
Pfizer 50
Testing effectiveness (Phase 2)Study completedNCT01918865
What this trial is testing

Safety, Tolerability, and Efficacy of ISIS-PTP1BRx in Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusObese
Ionis Pharmaceuticals, Inc. 92
Not applicableStudy completedNCT06794892
What this trial is testing

Comparative Outcomes of One-Anastomosis Gastric Bypass and Roux-en-Y Gastric Bypass As Revisional Procedures Following Failed Restrictive Bariatric Surgery

Who this might be right for
Obesity, MorbidType 2 Diabetes Mellitus (T2DM)Hypertension+1 more
Azienda Sanitaria Locale Napoli 2 Nord 328
Not applicableStudy completedNCT00361946
What this trial is testing

The Role of Amylin and Incretins on Postprandial Metabolisms in Adolescents With Type 2 Diabetes Mellitus (T2DM).

Who this might be right for
Type 2 Diabetes
Baylor College of Medicine 45
Not applicableStudy completedNCT04048642
What this trial is testing

Effects of a Plant-Based Diet on Insulin Requirements and Obesity Markers in Obese Adults With T2DM

Who this might be right for
Diabetes Mellitus, Type 2Insulin ResistanceObesity+1 more
University of Rochester 15
Not applicableUnknownNCT01752803
What this trial is testing

RCT Examining Effects of Probiotics in T2DM Individuals

Who this might be right for
Type 2 Diabetes MellitusObesityHypertension+1 more
Universiti Kebangsaan Malaysia Medical Centre 100
Not applicableLooking for participantsNCT06590519
What this trial is testing

Date Seed Extract Effectiveness in Controlling Diabetes and Cardiovascular Risk in T2DM

Who this might be right for
Type 2 Diabetes MellitusObesity
Universiti Putra Malaysia 160
Testing effectiveness (Phase 2)Ended earlyNCT03152552
What this trial is testing

A Dose Finding Study to Assess the Effect of LIK066 Compared to Placebo or Empagliflozin in Patients With Type 2 Diabetes Mellitus and Heart Failure

Who this might be right for
Diabetes Mellitus and Heart Failure
Novartis Pharmaceuticals 125
Not applicableUnknownNCT05957224
What this trial is testing

Differences in Postprandial Glucose Changes

Who this might be right for
Diabetes Mellitus, Type IIOverweight or Obesity
The University of The West Indies 25
Not applicableUnknownNCT03961659
What this trial is testing

Effects of Liraglutid, Dapagliflozin and Acarbose on the Cognitive Function, Olfactory Function, and Odor-induced Brain Activation in Overweight/Obese T2DM Patients Controlled Inadequately With Metformin Monotherapy.

Who this might be right for
Type 2 Diabetes MellitusObesityCognitive Impairment
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 87
Post-approval studies (Phase 4)UnknownNCT01718457
What this trial is testing

Endobarrier Treatment in Obese Subjects With T2DM

Who this might be right for
Type 2 DiabetesObesity
Sheba Medical Center 45
Not applicableActive Not RecruitingNCT06613711
What this trial is testing

MagDI Italian Study

Who this might be right for
ObesityType 2 Diabetes Mellitus (T2DM)Anastomosis
GT Metabolic Solutions, Inc. 60
Not applicableStudy completedNCT00413335
What this trial is testing

Effects of Rosiglitazone on the Metabolic Phenotype of Impaired Glucose Tolerance in Youth

Who this might be right for
ObesityImpaired Glucose ToleranceType 2 Diabetes Mellitus
Yale University 21
Early research (Phase 1)Study completedNCT06948747
What this trial is testing

Investigate the Effect of AZD5004 on Rosuvastatin, Atorvastatin, Simvastatin, Repaglinide and the Effect of Erythromycin on AZD5004 in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 49
Not applicableUnknownNCT02091323
What this trial is testing

Effect of Laparoscopic Roux-en-Y Gastric Bypass Surgery on Non-severe Obesity With Type 2 Diabetes Mellitus

Who this might be right for
Diabetes Mellitus, Non-Insulin-Dependent
Guangzhou General Hospital of Guangzhou Military Command 200
Early research (Phase 1)Study completedNCT00551564
What this trial is testing

Study to Determine the Utility of Novel Technologies and Biomarkers to Measure Human Response to Rosiglitazone Maleate

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 36
Load More Results